Clinical Trial Imaging Services Market Procurement Intelligence, Key Growth 2025
Posted by Manisha S on December 27th, 2021
Imaging plays an important role in modern medicine. Modern imaging techniques including X-rays, ultrasound, CT scans, and MRI shows structures inside the patient’s body in considerable detail. To improve decision making, increase efficiency and potentially reduce trial costs, sponsors need to work with an imaging partner that can provide strategic advice on biomarkers in early phase development and demonstrate how medical imaging endpoints can provide objective evidence of a drug’s safety and efficacy.
The core clinical imaging solution include protocol design, site selection, site training and support, electronic image transfer and de-identification, certified radiologic technologist image QC, independent blinded image review, clinical data management and biostatistics, preparation for audits, and regulatory and compliance decisions.
Read report summary or request a free sample copy of the report “Clinical Trial Imaging Services Market Procurement Intelligence, Supplier Intelligence, Supplier Ranking, Pricing & Cost Structure Intelligence, Best Practices, Engagement Model, Low & Best Cost Country, Day One Analysis Report, 2020 – 2025”
Imaging is currently being utilized in the following three areas:
The rise in clinical trials due to the surge in prevalence of chronic conditions, which require novel treatment option is driving the growth of the market. Project and data management is dominating the service type share in the market. It is also expected to witness the highest growth rate over the forecasted, as sponsors are outsourcing owing to high associated costs.
North America accounted for the major share of the clinical trial imaging services market and is expected to continue this trend owing to the surge in use of imaging as an endpoint in clinical trials which leads to sponsors outsourcing these services to save cost. Furthermore, the other major factor, which is the presence of major players such as Parexel International, ERT Clinical, Biospective, Inc. Intrinsic Imaging LLC leads to easy availability of clinical trial imaging service, which in turn boosts the growth of the market in the region.
High rise in cost for technological advancements and change in regulatory needs are few factors that compel pharmaceutical and biotechnology companies to outsource imaging services. Moreover, pharmaceutical companies are repeatedly engaged in the development of new therapeutics, which can be immensely expensive leading to a need to outsource.
Browse our other Reports:
A smart and effective supply chain is essential for growth in any organization. Pipeline division at Grand View Research provides detailed insights on every aspect of the supply chain which helps in efficient procurement decisions.
Our services include (not limited to):
· Market Intelligence involving - market size and forecast, growth factors, and driving trends
· Price and Cost Intelligence - pricing models adopted for the category, the total cost of ownership
· Supplier Intelligence - rich insight on supplier landscape, and identifies suppliers who are dominating, emerging, lounging, and specializing
· Sourcing / Procurement Intelligence - best practices followed in the industry, identifying standard KPIs and SLAs, peer analysis, negotiation strategies to be utilized with the suppliers, and best-suited countries for sourcing to minimize supply chain disruption
Our market/procurement Intelligence reports include in-depth and actionable insights that help clients in understanding the different aspects of the supply chain and take more effective decisions.
Like it? Share it!
About the AuthorManisha S
Joined: August 2nd, 2017
Articles Posted: 58
More by this author